A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients with Drug Resistant Epilepsy.
- O'Brien, Terence (Primary Chief Investigator (PCI))
- Mullen, Saul Alator (Chief Investigator (CI))
- Nicolo, John-Paul (Chief Investigator (CI))
Project: Research